Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000468029 | SCV000561796 | benign | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575853 | SCV000675209 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000468029 | SCV001745507 | likely benign | not provided | 2020-09-04 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821377 | SCV002070836 | likely benign | not specified | 2019-01-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000468029 | SCV005093426 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | SMARCB1: BP4, BP7, BS1 |
Breakthrough Genomics, |
RCV000468029 | SCV005209087 | likely benign | not provided | criteria provided, single submitter | not provided |